Home > Boards > US Listed > Biotechs >

CureVac B.V. (CVAC)

CVAC RSS Feed
Add CVAC Price Alert      Hide Sticky   Hide Intro
Moderator: mick, crudeoil24, @LaughinPaulRyan
Search This Board: 
Last Post: 9/24/2020 9:05:20 PM - Followers: 11 - Board type: Free - Posts Today: 0






https://www.curevac.com/about-curevac
https://www.curevac.com/what-we-do
https://www.curevac.com/our-pipeline
https://www.curevac.com/partnering
Arcturus Therapeutics

CureVac has entered into a collaboration with Arcturus Therapeutics Ltd. (NASDAQ:ARCT), an RNA medicines company,
to access the full suite of Arcturus’ lipid-mediated delivery intellectual property to enable the development of mRNA product candidates.

https://www.curevac.com/news-events


 

CureVac Announces Pricing of Initial Public Offering

08-14-2020
"" rel="nofollow ugc" target="_blank">https://www.curevac.com/news/curevac-announces-pricing-of-initial-public-offering"; style="box-sizing: border-box; -webkit-tap-highlight-color: transparent; outline: 0px; color: rgb(241, 110, 48); text-decoration-line: none; background-color: transparent; font-family: "Open Sans", sans-serif; font-weight: 600; margin-right: 20px; line-height: 22px;" target="_blank" rel="nofollow ugc"> Email Press Release  PDF version 

TÜBINGEN, Germany/ BOSTON, USA – August 14, 2020 – CureVac B.V. (“CureVac” or the “Company”), a clinical-stage biopharmaceutical company
developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced today the pricing of its
initial public offering of 13,333,333 common shares at an initial public offering price of $16.00 per common share, for total gross proceeds of approximately $213.3 million.
In addition, the Company has granted the underwriters a 30-day option to purchase up to an
additional 1,999,999 common shares at the public offering price, less underwriting discounts and commissions. All of the common shares are being offered by CureVac.
The shares are scheduled to begin trading on the Nasdaq Global Market today, August 14, 2020, under the ticker symbol “CVAC.”
The offering is expected to close on August 18, 2020, subject to customary closing conditions.

BofA Securities, Jefferies and Credit Suisse are acting as joint book-running managers for the proposed offering, with Berenberg and Kempen & Co acting as passive book-running managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (“SEC”) on August 13, 2020.
The offering is being made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained, when available,
for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the final prospectus, when available, may be obtained from
BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001,
by telephone at (800) 299-1322 or by email at dg.prospectus_requests@bofa.com; Jefferies LLC, Attention:
Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com;
and Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, by telephone at (800) 221-1037 or by email at usa.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities,
nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About CureVac
CureVac is a global clinical-stage biopharmaceutical company in the field of messenger RNA (mRNA) technology with expertise in developing
and optimizing this versatile molecule for medical purposes.
The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases.
The company applies its technologies for the development of prophylactic vaccines, cancer therapies,
antibody therapies and the treatment of protein therapies. CureVac is headquartered in Tübingen, Germany with sites in Frankfurt and Boston, USA.

CureVac Investor Relation Contact
Dr. Sarah Fakih, Vice President Investor Relations
CureVac, Tübingen, Germany
T: +49 7071 9883-1298
M: +49 160 90 496949
sarah.fakih@curevac.com

CureVac Media Contact
Thorsten Schüller, Director Corporate Communications
CureVac, Tübingen, Germany
T: +49 7071 9883-1577
thorsten.schueller@curevac.com
sarah.fakih@curevac.com



 *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.













 

CVAC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CVAC News: Report of Foreign Issuer (6-k) 09/04/2020 08:41:49 AM
CVAC News: Post-effective Amendment to an S-8 Filing (s-8 Pos) 08/27/2020 10:20:44 AM
PostSubject
#54  Sticky Note ... BEFORE IT'S NEWS: TESLA AND CUREVAC ... #BREAKINGNEWS @LaughinPaulRyan 09/02/20 09:30:41 AM
#64   CureVac NV (CVAC) mick 09/24/20 09:05:20 PM
#63   ... dip baby, dip baby ... $CVAC @LaughinPaulRyan 09/12/20 05:42:52 PM
#62   ... hope this goes below $40 again shortly @LaughinPaulRyan 09/08/20 01:36:16 PM
#61   CureVac NV (CVAC) mick 09/05/20 03:55:14 PM
#60   CureVac Expected to Receive up to 252 million @LaughinPaulRyan 09/04/20 08:55:14 AM
#59   "Musk announced in July that Tesla was building crudeoil24 09/04/20 08:11:08 AM
#58   ... looking for a significant drop to buy @LaughinPaulRyan 09/03/20 12:51:58 PM
#57   ... CNBC COVERS TESLA CEO AT CUREVAC ... @LaughinPaulRyan 09/03/20 04:58:42 AM
#56   ... ELON GIVES THE $CVAC NEWS ... @LaughinPaulRyan 09/03/20 04:32:21 AM
#55   ... CUREVAC AND TESLA PATENT REVEALED ... $CVAC @LaughinPaulRyan 09/02/20 10:07:59 AM
#54   ... BEFORE IT'S NEWS: TESLA AND CUREVAC ... #BREAKINGNEWS @LaughinPaulRyan 09/02/20 09:30:41 AM
#53   ... ANOTHER 1 - $CVAC TO $100 ... #BREAKINGNEWS @LaughinPaulRyan 08/27/20 11:55:43 AM
#52   $CVAC / #Curevac Potential Continuation Targets TFMG 08/25/20 10:05:37 AM
#51   ... definately a quiet buying opportunity again ... @LaughinPaulRyan 08/24/20 12:12:47 PM
#50   $CVAC Meanwhile, in a call with reporters Thursday mick 08/20/20 09:43:09 PM
#49   * * $CVAC Video Chart 08-20-2020 * * ClayTrader 08/20/20 06:18:00 PM
#48   I like it! Keep goin! Kloby 08/20/20 09:03:57 AM
#47   Up 15% @ 65.55 crudeoil24 08/20/20 08:13:36 AM
#46   Up 10% > CureVac shares are trading higher crudeoil24 08/20/20 07:51:30 AM
#45   Once they can deliver vaccine injections that magically NYCPuglet 08/19/20 12:51:36 PM
#44   Waiting for this to get into the $40.00s Noonehasthisusername 08/19/20 12:20:35 PM
#43   It's all about "RAPID RESPONSE" > $$$$$ crudeoil24 08/18/20 08:18:39 AM
#42   mRNA technology has the advantage over Fezziwig2008 08/18/20 07:45:20 AM
#41   I didn't make any call, I just bought dinogreeves 08/17/20 06:31:08 PM
#40   I like the risk /reward for a hold Kloby 08/17/20 06:29:21 PM
#39   * * $CVAC Video Chart 08-17-2020 * * ClayTrader 08/17/20 06:22:18 PM
#38   The company indicated yesterday that it can come dinogreeves 08/17/20 06:13:26 PM
#37   I agree I think it can run if Kloby 08/17/20 06:09:50 PM
#36   Neve mind what I say, you do, what dinogreeves 08/17/20 05:41:26 PM
#35   Why do you say that?! Kloby 08/17/20 04:33:25 PM
#34   CVAC is going to run to 200 within dinogreeves 08/17/20 04:06:52 PM
#33   CVAC - Dirk and Bionewman -Self proclaimed Biotech Fezziwig2008 08/17/20 02:36:43 PM
#32   CUREVAC & TESLA >> "CureVac also has another crudeoil24 08/17/20 07:05:15 AM
#31   CureVac is a leading company in the field crudeoil24 08/17/20 07:04:20 AM
#30   ... this is a watershed moment for the @LaughinPaulRyan 08/17/20 06:20:23 AM
#29   CVAC-I can’t keep my eyes off of it Fezziwig2008 08/17/20 05:45:40 AM
#28   So how do you invest in this company? kmack49 08/16/20 12:21:44 PM
#27   Just Out “ CVAC Doesn't Rule Out Accelerated Fezziwig2008 08/16/20 10:08:28 AM
#26   CVAC “ As determined by the Securities and Fezziwig2008 08/16/20 01:45:23 AM
#25   MRNA doses 12x-50x the vaccine dose CVAC requires Fezziwig2008 08/15/20 01:07:05 AM
#24   “What makes CureVac different from the rivals in Fezziwig2008 08/15/20 12:57:24 AM
#23   CVAC CEO (contd Endpoints article) “Haas says he Fezziwig2008 08/15/20 12:55:22 AM
#22   CVAC ”CEO Franz-Werner Haas outlined plans to start Fezziwig2008 08/15/20 12:49:51 AM
#21   CVAC “CureVac’s vaccines — which have never made Fezziwig2008 08/14/20 11:33:58 PM
#20   nice one man koolmc 08/14/20 08:11:51 PM
#19   TSLA -CVAC https://www.fiercepharma.com/manufacturing/curevac-teaming-up-tesla-t Fezziwig2008 08/14/20 04:42:45 PM
#18   CVAC happy to have a foothold on this Fezziwig2008 08/14/20 04:12:36 PM
#17   $CVAC WORKING WIT TSLA mick 08/14/20 04:00:29 PM
#16   $CVAC Bid: 54.35 Ask: 54.65 Last: 54.57 Chg mick 08/14/20 03:56:51 PM
#15   $CVAC 50.05 +34.05 +212.81% USD 3:16PM EDT 18.240M mick 08/14/20 03:55:21 PM
PostSubject
Consent Preferences